

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.07651623 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.96216854 |
| 3 | regulation of meiosis (GO:0040020) | 4.76323268 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71757151 |
| 5 | regulation of meiosis I (GO:0060631) | 4.71483781 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.64737631 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.64737631 |
| 8 | piRNA metabolic process (GO:0034587) | 4.62440023 |
| 9 | chaperone-mediated protein transport (GO:0072321) | 4.52915665 |
| 10 | glycerophospholipid catabolic process (GO:0046475) | 4.47180296 |
| 11 | regulation of female gonad development (GO:2000194) | 4.36742722 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.32835586 |
| 13 | DNA deamination (GO:0045006) | 4.30922000 |
| 14 | regulation of RIG-I signaling pathway (GO:0039535) | 4.26477861 |
| 15 | female gamete generation (GO:0007292) | 4.21864220 |
| 16 | negative regulation of meiosis (GO:0045835) | 4.13973106 |
| 17 | cytidine metabolic process (GO:0046087) | 4.12932725 |
| 18 | cytidine catabolic process (GO:0006216) | 4.12932725 |
| 19 | cytidine deamination (GO:0009972) | 4.12932725 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.09080279 |
| 21 | regulation of meiotic cell cycle (GO:0051445) | 3.97901984 |
| 22 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.91387745 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.87658249 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.85366223 |
| 25 | regulation of exit from mitosis (GO:0007096) | 3.84743695 |
| 26 | maturation of 5.8S rRNA (GO:0000460) | 3.84351912 |
| 27 | negative regulation of hormone metabolic process (GO:0032351) | 3.82976831 |
| 28 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.82976831 |
| 29 | regulation of histone H3-K27 methylation (GO:0061085) | 3.82195043 |
| 30 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.70076759 |
| 31 | negative T cell selection (GO:0043383) | 3.63180436 |
| 32 | mitotic metaphase plate congression (GO:0007080) | 3.61975340 |
| 33 | positive regulation of granulocyte differentiation (GO:0030854) | 3.61184986 |
| 34 | regulation of cell maturation (GO:1903429) | 3.60317792 |
| 35 | meiotic cell cycle (GO:0051321) | 3.59856485 |
| 36 | male meiosis (GO:0007140) | 3.56745231 |
| 37 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.56055065 |
| 38 | positive regulation of mitochondrial fission (GO:0090141) | 3.55993787 |
| 39 | snRNA transcription (GO:0009301) | 3.53392757 |
| 40 | cellular response to interleukin-15 (GO:0071350) | 3.51732769 |
| 41 | DNA damage induced protein phosphorylation (GO:0006975) | 3.49937482 |
| 42 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.49855805 |
| 43 | negative thymic T cell selection (GO:0045060) | 3.47500359 |
| 44 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.46041853 |
| 45 | oocyte maturation (GO:0001556) | 3.43098849 |
| 46 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.41982541 |
| 47 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.41982541 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.39336611 |
| 49 | negative regulation of meiotic cell cycle (GO:0051447) | 3.38397314 |
| 50 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.37050388 |
| 51 | neutrophil activation (GO:0042119) | 3.36393936 |
| 52 | response to interleukin-15 (GO:0070672) | 3.34087764 |
| 53 | immunoglobulin mediated immune response (GO:0016064) | 3.32486659 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.29895126 |
| 55 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.28478430 |
| 56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.27862910 |
| 57 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.26573247 |
| 58 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.23602157 |
| 59 | regulation of gamma-delta T cell activation (GO:0046643) | 3.22889138 |
| 60 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.19420280 |
| 61 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18862483 |
| 62 | mast cell activation (GO:0045576) | 3.18019481 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.15786119 |
| 64 | microtubule nucleation (GO:0007020) | 3.15498582 |
| 65 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14305066 |
| 66 | microtubule severing (GO:0051013) | 3.13938194 |
| 67 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.12066294 |
| 68 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.10823470 |
| 69 | myoblast migration (GO:0051451) | 3.09758455 |
| 70 | regulation of DNA methylation (GO:0044030) | 3.08982388 |
| 71 | response to redox state (GO:0051775) | 3.07324718 |
| 72 | granulocyte activation (GO:0036230) | 3.04501832 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.04262093 |
| 74 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.03913460 |
| 75 | regulation of mast cell activation (GO:0033003) | 3.03511757 |
| 76 | positive regulation of mast cell activation (GO:0033005) | 3.03349420 |
| 77 | positive thymic T cell selection (GO:0045059) | 3.02279701 |
| 78 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.01817183 |
| 79 | photoreceptor cell differentiation (GO:0046530) | 3.00209975 |
| 80 | eye photoreceptor cell differentiation (GO:0001754) | 3.00209975 |
| 81 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.99899757 |
| 82 | DNA methylation involved in gamete generation (GO:0043046) | 2.99865743 |
| 83 | central nervous system myelination (GO:0022010) | 2.99608445 |
| 84 | axon ensheathment in central nervous system (GO:0032291) | 2.99608445 |
| 85 | male meiosis I (GO:0007141) | 2.98839264 |
| 86 | leukocyte degranulation (GO:0043299) | 2.97415004 |
| 87 | metaphase plate congression (GO:0051310) | 2.95540006 |
| 88 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.95410790 |
| 89 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95379965 |
| 90 | actin nucleation (GO:0045010) | 2.95259597 |
| 91 | regulation of germinal center formation (GO:0002634) | 2.94610987 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.94556063 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 2.94150697 |
| 94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93376996 |
| 95 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.92352279 |
| 96 | meiosis I (GO:0007127) | 2.91993788 |
| 97 | activated T cell proliferation (GO:0050798) | 2.88996346 |
| 98 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.88201956 |
| 99 | detection of bacterium (GO:0016045) | 2.88078838 |
| 100 | detection of other organism (GO:0098543) | 2.87549683 |
| 101 | protein neddylation (GO:0045116) | 2.87177114 |
| 102 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.87146271 |
| 103 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.87045660 |
| 104 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.87045660 |
| 105 | dopamine biosynthetic process (GO:0042416) | 2.86746329 |
| 106 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.86736590 |
| 107 | tolerance induction (GO:0002507) | 2.86396956 |
| 108 | regulation of memory T cell differentiation (GO:0043380) | 2.85202945 |
| 109 | establishment of chromosome localization (GO:0051303) | 2.84231369 |
| 110 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.83669882 |
| 111 | response to interferon-beta (GO:0035456) | 2.83646780 |
| 112 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.83297686 |
| 113 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.83297686 |
| 114 | microtubule polymerization or depolymerization (GO:0031109) | 2.83191970 |
| 115 | protein autoubiquitination (GO:0051865) | 2.82863239 |
| 116 | parturition (GO:0007567) | 2.80088604 |
| 117 | positive T cell selection (GO:0043368) | 2.78379044 |
| 118 | negative regulation of T cell mediated immunity (GO:0002710) | 2.77113931 |
| 119 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.76931962 |
| 120 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.76357313 |
| 121 | regulation of mitochondrial fission (GO:0090140) | 2.75234032 |
| 122 | autophagic vacuole fusion (GO:0000046) | 2.74509084 |
| 123 | regulation of mast cell degranulation (GO:0043304) | 2.74258305 |
| 124 | leukocyte aggregation (GO:0070486) | 2.72905497 |
| 125 | microglial cell activation (GO:0001774) | 2.72558788 |
| 126 | myeloid cell activation involved in immune response (GO:0002275) | 2.71927018 |
| 127 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.71603016 |
| 128 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.71603016 |
| 129 | regulation of histone phosphorylation (GO:0033127) | 2.71449121 |
| 130 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.69942183 |
| 131 | B cell mediated immunity (GO:0019724) | 2.69718438 |
| 132 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.68688952 |
| 133 | sphingosine metabolic process (GO:0006670) | 2.68598839 |
| 134 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.68021254 |
| 135 | protein polyglutamylation (GO:0018095) | 2.66607020 |
| 136 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.66511793 |
| 137 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.66344343 |
| 138 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.66344343 |
| 139 | modulation by symbiont of host immune response (GO:0052553) | 2.66344343 |
| 140 | positive regulation by symbiont of host defense response (GO:0052509) | 2.66344343 |
| 141 | modulation by symbiont of host defense response (GO:0052031) | 2.66344343 |
| 142 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.66344343 |
| 143 | dendritic cell migration (GO:0036336) | 2.66174158 |
| 144 | protein K48-linked ubiquitination (GO:0070936) | 2.65302212 |
| 145 | protein deneddylation (GO:0000338) | 2.64666457 |
| 146 | negative regulation of interleukin-12 production (GO:0032695) | 2.63628306 |
| 147 | protein-chromophore linkage (GO:0018298) | 2.62725463 |
| 148 | positive regulation of antigen processing and presentation (GO:0002579) | 2.62238832 |
| 149 | positive regulation of mast cell degranulation (GO:0043306) | 2.61538312 |
| 150 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.61538312 |
| 151 | protein K6-linked ubiquitination (GO:0085020) | 2.61185959 |
| 152 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.61021917 |
| 153 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.60983670 |
| 154 | regulation of mononuclear cell migration (GO:0071675) | 2.60880044 |
| 155 | regulation of cell killing (GO:0031341) | 2.60583975 |
| 156 | 7-methylguanosine mRNA capping (GO:0006370) | 2.60528078 |
| 157 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.60270979 |
| 158 | centriole replication (GO:0007099) | 2.60101273 |
| 159 | histone H2A ubiquitination (GO:0033522) | 2.60066573 |
| 160 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.59696555 |
| 161 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.59309542 |
| 162 | 7-methylguanosine RNA capping (GO:0009452) | 2.58720527 |
| 163 | RNA capping (GO:0036260) | 2.58720527 |
| 164 | dendritic cell chemotaxis (GO:0002407) | 2.58617667 |
| 165 | female gonad development (GO:0008585) | 2.57001255 |
| 166 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.56813259 |
| 167 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.55598138 |
| 168 | mast cell activation involved in immune response (GO:0002279) | 2.55087510 |
| 169 | mast cell degranulation (GO:0043303) | 2.55087510 |
| 170 | T cell selection (GO:0045058) | 2.54334027 |
| 171 | rhodopsin mediated signaling pathway (GO:0016056) | 2.54326616 |
| 172 | regulation of antigen processing and presentation (GO:0002577) | 2.53608848 |
| 173 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.53164669 |
| 174 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.52731780 |
| 175 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.52628812 |
| 176 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.52628812 |
| 177 | cellular response to interferon-beta (GO:0035458) | 2.52275988 |
| 178 | interferon-gamma production (GO:0032609) | 2.52161004 |
| 179 | negative regulation of T cell apoptotic process (GO:0070233) | 2.51959240 |
| 180 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.51605500 |
| 181 | type B pancreatic cell development (GO:0003323) | 2.50575368 |
| 182 | positive regulation of cell killing (GO:0031343) | 2.50221963 |
| 183 | regulation of protein targeting to membrane (GO:0090313) | 2.49043602 |
| 184 | organelle membrane fusion (GO:0090174) | 2.48194806 |
| 185 | response to host immune response (GO:0052572) | 2.47782176 |
| 186 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.47782176 |
| 187 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.47440608 |
| 188 | righting reflex (GO:0060013) | 2.47184818 |
| 189 | protein K11-linked ubiquitination (GO:0070979) | 2.46827349 |
| 190 | positive regulation of protein targeting to membrane (GO:0090314) | 2.44906365 |
| 191 | respiratory chain complex IV assembly (GO:0008535) | 2.43372708 |
| 192 | positive regulation of defense response to virus by host (GO:0002230) | 2.43165792 |
| 193 | negative regulation of circadian rhythm (GO:0042754) | 2.42514447 |
| 194 | positive regulation of meiosis (GO:0045836) | 2.40882161 |
| 195 | meiotic chromosome segregation (GO:0045132) | 2.37990516 |
| 196 | cellular response to gamma radiation (GO:0071480) | 2.37408299 |
| 197 | GPI anchor biosynthetic process (GO:0006506) | 2.35752962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.82477808 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.53293241 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.03803873 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.80639800 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.59956864 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.49672319 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.07869199 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.07587734 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.07232960 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.91736879 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.85847776 |
| 12 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.80562114 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.69132273 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.65752346 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.64568316 |
| 16 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60504363 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.55958125 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.44922487 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.41518943 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.25189247 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.20179454 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.12641825 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12068490 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.10036682 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08215949 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06615985 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.05887952 |
| 28 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04260513 |
| 29 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.98099351 |
| 30 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.97677184 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.97023941 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.91561204 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.89826939 |
| 34 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.87031798 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85528971 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.84897240 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84580159 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.76555024 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73448079 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71220794 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.71143277 |
| 42 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70517436 |
| 43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.69655450 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.67545000 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65856963 |
| 46 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.65643216 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65080855 |
| 48 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.63443680 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.60801358 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57957915 |
| 51 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56374216 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54580485 |
| 53 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53847725 |
| 54 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53844804 |
| 55 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.53836628 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51265224 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50948916 |
| 58 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.43516310 |
| 59 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.42086744 |
| 60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41562066 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41136126 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40422276 |
| 63 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39596808 |
| 64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38710370 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.38157087 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37988972 |
| 67 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36585034 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36528488 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34097863 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33241984 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32534879 |
| 72 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.31842611 |
| 73 | EWS_26573619_Chip-Seq_HEK293_Human | 1.31650745 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29937585 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29675568 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27471958 |
| 77 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.26765238 |
| 78 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.25834557 |
| 79 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25707250 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24565640 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24546280 |
| 82 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.24278449 |
| 83 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.23637138 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22892573 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22751594 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22525874 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22287956 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20816734 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 1.20355105 |
| 90 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.19571269 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19511288 |
| 92 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19220898 |
| 93 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18877265 |
| 94 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.18502958 |
| 95 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.18055264 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17620099 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16717404 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16665061 |
| 99 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.16351590 |
| 100 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15467892 |
| 101 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15378931 |
| 102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15378931 |
| 103 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14553345 |
| 104 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.13759084 |
| 105 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13702025 |
| 106 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.13614427 |
| 107 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13080490 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12062670 |
| 109 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10957665 |
| 110 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10778182 |
| 111 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.10539736 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10226692 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08361774 |
| 114 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08132820 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08008530 |
| 116 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07902794 |
| 117 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07540174 |
| 118 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07435718 |
| 119 | GATA3_26560356_Chip-Seq_TH1_Human | 1.07012351 |
| 120 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06843760 |
| 121 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.06136522 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05941610 |
| 123 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05730921 |
| 124 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04710061 |
| 125 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04288773 |
| 126 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.04231085 |
| 127 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04084854 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03197627 |
| 129 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03067999 |
| 130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03017542 |
| 131 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.02587015 |
| 132 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02519773 |
| 133 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02294869 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02163803 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02048487 |
| 136 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01979713 |
| 137 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.01896153 |
| 138 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.01724452 |
| 139 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01556673 |
| 140 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01540870 |
| 141 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01453900 |
| 142 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01392104 |
| 143 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01315223 |
| 144 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.00975977 |
| 145 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00933067 |
| 146 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00933067 |
| 147 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00803123 |
| 148 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00568741 |
| 149 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.00197013 |
| 150 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99965955 |
| 151 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99783950 |
| 152 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99527946 |
| 153 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99527946 |
| 154 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99336007 |
| 155 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99196655 |
| 156 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98679137 |
| 157 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97622493 |
| 158 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97094946 |
| 159 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96264100 |
| 160 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95968352 |
| 161 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.95485126 |
| 162 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.95426032 |
| 163 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95240419 |
| 164 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94287763 |
| 165 | MAF_26560356_Chip-Seq_TH2_Human | 0.93296546 |
| 166 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93201547 |
| 167 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92573134 |
| 168 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92415923 |
| 169 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.92130660 |
| 170 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92059319 |
| 171 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.91457763 |
| 172 | JUN_21703547_ChIP-Seq_K562_Human | 0.91144907 |
| 173 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.91136976 |
| 174 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.91126676 |
| 175 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91029673 |
| 176 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90957278 |
| 177 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90782948 |
| 178 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90425638 |
| 179 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89915178 |
| 180 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89009338 |
| 181 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88486364 |
| 182 | * P300_27268052_Chip-Seq_Bcells_Human | 0.87016399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.07704611 |
| 2 | MP0003724_increased_susceptibility_to | 4.04200677 |
| 3 | MP0003646_muscle_fatigue | 3.61461816 |
| 4 | MP0001529_abnormal_vocalization | 3.47270796 |
| 5 | MP0002102_abnormal_ear_morphology | 3.40562603 |
| 6 | MP0003718_maternal_effect | 3.31558542 |
| 7 | MP0001905_abnormal_dopamine_level | 2.90055814 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.74090172 |
| 9 | MP0003436_decreased_susceptibility_to | 2.73402285 |
| 10 | MP0001800_abnormal_humoral_immune | 2.71274258 |
| 11 | MP0003880_abnormal_central_pattern | 2.65067885 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.62560167 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.60161616 |
| 14 | MP0000685_abnormal_immune_system | 2.57084259 |
| 15 | MP0006292_abnormal_olfactory_placode | 2.41017515 |
| 16 | MP0005025_abnormal_response_to | 2.39885470 |
| 17 | MP0003787_abnormal_imprinting | 2.37394372 |
| 18 | MP0001790_abnormal_immune_system | 2.37141642 |
| 19 | MP0005387_immune_system_phenotype | 2.37141642 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.28331953 |
| 21 | MP0002638_abnormal_pupillary_reflex | 2.26587258 |
| 22 | MP0001819_abnormal_immune_cell | 2.26161739 |
| 23 | MP0002419_abnormal_innate_immunity | 2.25659803 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.20683289 |
| 25 | MP0005310_abnormal_salivary_gland | 2.14709142 |
| 26 | MP0008260_abnormal_autophagy | 2.11914507 |
| 27 | MP0005646_abnormal_pituitary_gland | 2.08321152 |
| 28 | MP0004270_analgesia | 2.06880968 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 2.02111204 |
| 30 | MP0010386_abnormal_urinary_bladder | 1.96521809 |
| 31 | MP0005408_hypopigmentation | 1.81044459 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.78715673 |
| 33 | MP0000716_abnormal_immune_system | 1.72381658 |
| 34 | MP0002736_abnormal_nociception_after | 1.72249773 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.71011907 |
| 36 | MP0006072_abnormal_retinal_apoptosis | 1.70619236 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.68778980 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.68670837 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.68153417 |
| 40 | MP0009764_decreased_sensitivity_to | 1.66438022 |
| 41 | MP0002405_respiratory_system_inflammati | 1.62609811 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.61169481 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.57297911 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.55603055 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.54960262 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.54813164 |
| 47 | MP0003303_peritoneal_inflammation | 1.53670211 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.51827351 |
| 49 | MP0001984_abnormal_olfaction | 1.51276316 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.50596672 |
| 51 | MP0001119_abnormal_female_reproductive | 1.50582965 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.49421403 |
| 53 | MP0002722_abnormal_immune_system | 1.48794923 |
| 54 | MP0003866_abnormal_defecation | 1.48233709 |
| 55 | MP0003699_abnormal_female_reproductive | 1.47046328 |
| 56 | MP0002272_abnormal_nervous_system | 1.45239981 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.43444932 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.43444932 |
| 59 | MP0004381_abnormal_hair_follicle | 1.43439630 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.42059297 |
| 61 | MP0000920_abnormal_myelination | 1.41512755 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.40886902 |
| 63 | MP0002429_abnormal_blood_cell | 1.39649307 |
| 64 | MP0002132_abnormal_respiratory_system | 1.38184651 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.37130088 |
| 66 | MP0001929_abnormal_gametogenesis | 1.36872502 |
| 67 | MP0001968_abnormal_touch/_nociception | 1.34037311 |
| 68 | MP0005671_abnormal_response_to | 1.32332491 |
| 69 | MP0003077_abnormal_cell_cycle | 1.32080136 |
| 70 | MP0008469_abnormal_protein_level | 1.31370386 |
| 71 | MP0001346_abnormal_lacrimal_gland | 1.31159547 |
| 72 | MP0008872_abnormal_physiological_respon | 1.30940734 |
| 73 | MP0003693_abnormal_embryo_hatching | 1.28443611 |
| 74 | MP0000653_abnormal_sex_gland | 1.27105851 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 1.25210705 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 1.24515237 |
| 77 | MP0005395_other_phenotype | 1.23697778 |
| 78 | MP0005083_abnormal_biliary_tract | 1.22641031 |
| 79 | MP0001970_abnormal_pain_threshold | 1.21580910 |
| 80 | MP0003635_abnormal_synaptic_transmissio | 1.19522854 |
| 81 | MP0001851_eye_inflammation | 1.19116795 |
| 82 | MP0001501_abnormal_sleep_pattern | 1.19114048 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.18775306 |
| 84 | MP0004147_increased_porphyrin_level | 1.18684789 |
| 85 | MP0005386_behavior/neurological_phenoty | 1.18604709 |
| 86 | MP0004924_abnormal_behavior | 1.18604709 |
| 87 | MP0001486_abnormal_startle_reflex | 1.18169598 |
| 88 | MP0010094_abnormal_chromosome_stability | 1.17046180 |
| 89 | MP0002229_neurodegeneration | 1.16961067 |
| 90 | MP0003045_fibrosis | 1.15125249 |
| 91 | MP0003763_abnormal_thymus_physiology | 1.14231097 |
| 92 | MP0003329_amyloid_beta_deposits | 1.12828024 |
| 93 | MP0004859_abnormal_synaptic_plasticity | 1.12732066 |
| 94 | MP0002210_abnormal_sex_determination | 1.12604541 |
| 95 | MP0000015_abnormal_ear_pigmentation | 1.12533450 |
| 96 | MP0002163_abnormal_gland_morphology | 1.11427938 |
| 97 | MP0003195_calcinosis | 1.08719972 |
| 98 | MP0005174_abnormal_tail_pigmentation | 1.06354788 |
| 99 | MP0000639_abnormal_adrenal_gland | 1.04655422 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 1.04534959 |
| 101 | MP0009333_abnormal_splenocyte_physiolog | 1.03286529 |
| 102 | MP0001853_heart_inflammation | 1.02799681 |
| 103 | MP0004142_abnormal_muscle_tone | 1.02729025 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 1.02305501 |
| 105 | MP0004947_skin_inflammation | 1.01805120 |
| 106 | MP0003123_paternal_imprinting | 1.01559791 |
| 107 | MP0006036_abnormal_mitochondrial_physio | 1.01224729 |
| 108 | MP0002064_seizures | 1.00168009 |
| 109 | MP0002067_abnormal_sensory_capabilities | 0.99758565 |
| 110 | MP0002006_tumorigenesis | 0.98520589 |
| 111 | MP0003879_abnormal_hair_cell | 0.97731361 |
| 112 | MP0002572_abnormal_emotion/affect_behav | 0.97368469 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.97035037 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.95495746 |
| 115 | MP0004510_myositis | 0.94946824 |
| 116 | MP0005253_abnormal_eye_physiology | 0.94829382 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.94415536 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.93990552 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.93882973 |
| 120 | MP0003121_genomic_imprinting | 0.92278459 |
| 121 | MP0006082_CNS_inflammation | 0.92225169 |
| 122 | MP0004130_abnormal_muscle_cell | 0.91991293 |
| 123 | MP0009763_increased_sensitivity_to | 0.91373856 |
| 124 | MP0003632_abnormal_nervous_system | 0.90760516 |
| 125 | MP0009745_abnormal_behavioral_response | 0.90436572 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.90132812 |
| 127 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89574913 |
| 128 | MP0001873_stomach_inflammation | 0.89492059 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.88916641 |
| 130 | MP0002161_abnormal_fertility/fecundity | 0.88704113 |
| 131 | MP0002735_abnormal_chemical_nociception | 0.88447021 |
| 132 | MP0002733_abnormal_thermal_nociception | 0.88009407 |
| 133 | MP0004742_abnormal_vestibular_system | 0.87724259 |
| 134 | MP0003172_abnormal_lysosome_physiology | 0.86287769 |
| 135 | MP0008004_abnormal_stomach_pH | 0.85466513 |
| 136 | MP0004957_abnormal_blastocyst_morpholog | 0.84944067 |
| 137 | MP0001485_abnormal_pinna_reflex | 0.84587294 |
| 138 | MP0009046_muscle_twitch | 0.84291260 |
| 139 | MP0002095_abnormal_skin_pigmentation | 0.83313340 |
| 140 | MP0002063_abnormal_learning/memory/cond | 0.82799308 |
| 141 | MP0001963_abnormal_hearing_physiology | 0.82249724 |
| 142 | MP0008995_early_reproductive_senescence | 0.82216343 |
| 143 | MP0005195_abnormal_posterior_eye | 0.81960376 |
| 144 | MP0002693_abnormal_pancreas_physiology | 0.81675683 |
| 145 | MP0001188_hyperpigmentation | 0.81416702 |
| 146 | MP0001145_abnormal_male_reproductive | 0.80874174 |
| 147 | MP0000631_abnormal_neuroendocrine_gland | 0.79364193 |
| 148 | MP0003186_abnormal_redox_activity | 0.79248067 |
| 149 | MP0009785_altered_susceptibility_to | 0.79170411 |
| 150 | MP0003252_abnormal_bile_duct | 0.79164081 |
| 151 | MP0000569_abnormal_digit_pigmentation | 0.79010794 |
| 152 | MP0002882_abnormal_neuron_morphology | 0.77663278 |
| 153 | MP0001835_abnormal_antigen_presentation | 0.76748540 |
| 154 | MP0003698_abnormal_male_reproductive | 0.75510248 |
| 155 | MP0005000_abnormal_immune_tolerance | 0.75259236 |
| 156 | MP0005379_endocrine/exocrine_gland_phen | 0.74912584 |
| 157 | MP0003638_abnormal_response/metabolism_ | 0.74885321 |
| 158 | MP0000462_abnormal_digestive_system | 0.74356618 |
| 159 | MP0003183_abnormal_peptide_metabolism | 0.74349861 |
| 160 | MP0002933_joint_inflammation | 0.73852154 |
| 161 | MP0002184_abnormal_innervation | 0.72571842 |
| 162 | MP0005535_abnormal_body_temperature | 0.71781466 |
| 163 | MP0008007_abnormal_cellular_replicative | 0.70981060 |
| 164 | MP0002723_abnormal_immune_serum | 0.70691926 |
| 165 | MP0003011_delayed_dark_adaptation | 0.70135908 |
| 166 | MP0001764_abnormal_homeostasis | 0.69428132 |
| 167 | MP0003300_gastrointestinal_ulcer | 0.69383307 |
| 168 | MP0002396_abnormal_hematopoietic_system | 0.69098773 |
| 169 | MP0009278_abnormal_bone_marrow | 0.69073531 |
| 170 | MP0001663_abnormal_digestive_system | 0.68105695 |
| 171 | MP0005389_reproductive_system_phenotype | 0.68034534 |
| 172 | MP0002420_abnormal_adaptive_immunity | 0.67962035 |
| 173 | MP0002398_abnormal_bone_marrow | 0.67511038 |
| 174 | MP0001440_abnormal_grooming_behavior | 0.67287304 |
| 175 | MP0009643_abnormal_urine_homeostasis | 0.66366824 |
| 176 | MP0005319_abnormal_enzyme/_coenzyme | 0.65458526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.50379885 |
| 2 | Stomatitis (HP:0010280) | 4.38441041 |
| 3 | Male infertility (HP:0003251) | 4.37234328 |
| 4 | Myositis (HP:0100614) | 3.81177562 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 3.75452721 |
| 6 | Abnormal hair whorl (HP:0010721) | 3.72488292 |
| 7 | Hypochromic microcytic anemia (HP:0004840) | 3.61106577 |
| 8 | Adrenal hypoplasia (HP:0000835) | 3.60937775 |
| 9 | Pancreatic fibrosis (HP:0100732) | 3.60530015 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57154759 |
| 11 | Congenital stationary night blindness (HP:0007642) | 3.51995828 |
| 12 | Abnormality of macular pigmentation (HP:0008002) | 3.51947946 |
| 13 | IgG deficiency (HP:0004315) | 3.34068182 |
| 14 | Abnormality of T cell number (HP:0011839) | 3.28063785 |
| 15 | T lymphocytopenia (HP:0005403) | 3.22648817 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.21368241 |
| 17 | Petechiae (HP:0000967) | 3.14190308 |
| 18 | Orchitis (HP:0100796) | 3.10111000 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.07406705 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.07343485 |
| 21 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.06812628 |
| 22 | Hypoplasia of the fovea (HP:0007750) | 3.06812628 |
| 23 | Nonprogressive disorder (HP:0003680) | 3.06314585 |
| 24 | Parakeratosis (HP:0001036) | 3.06197455 |
| 25 | Abnormality of the fovea (HP:0000493) | 3.03120194 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.01899909 |
| 27 | Encephalitis (HP:0002383) | 3.00098050 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 2.97063470 |
| 29 | Papillary thyroid carcinoma (HP:0002895) | 2.96670441 |
| 30 | Abnormality of T cells (HP:0002843) | 2.93378951 |
| 31 | Meningitis (HP:0001287) | 2.92404435 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91622033 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91622033 |
| 34 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.89646170 |
| 35 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.89309039 |
| 36 | Medial flaring of the eyebrow (HP:0010747) | 2.88062581 |
| 37 | Type 2 muscle fiber atrophy (HP:0003554) | 2.87971689 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.86364538 |
| 39 | Gait imbalance (HP:0002141) | 2.85631143 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84890939 |
| 41 | Obstructive lung disease (HP:0006536) | 2.84890939 |
| 42 | Prostate neoplasm (HP:0100787) | 2.84069083 |
| 43 | Congenital primary aphakia (HP:0007707) | 2.83940503 |
| 44 | Atonic seizures (HP:0010819) | 2.83273700 |
| 45 | Pancreatic cysts (HP:0001737) | 2.81669438 |
| 46 | Vasculitis (HP:0002633) | 2.81172069 |
| 47 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.77085713 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.77025182 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.76783669 |
| 50 | Nephrogenic diabetes insipidus (HP:0009806) | 2.75755494 |
| 51 | Leukocytosis (HP:0001974) | 2.74723803 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.74456862 |
| 53 | Poor coordination (HP:0002370) | 2.72194325 |
| 54 | Hypochromic anemia (HP:0001931) | 2.66582120 |
| 55 | Microcytic anemia (HP:0001935) | 2.62990773 |
| 56 | Recurrent skin infections (HP:0001581) | 2.59003180 |
| 57 | True hermaphroditism (HP:0010459) | 2.58502777 |
| 58 | Abnormality of eosinophils (HP:0001879) | 2.57947504 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.57538164 |
| 60 | Flat capital femoral epiphysis (HP:0003370) | 2.57048691 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.56084433 |
| 62 | Genital tract atresia (HP:0001827) | 2.53820002 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.53260041 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.51692012 |
| 65 | Focal motor seizures (HP:0011153) | 2.50245962 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.49834630 |
| 67 | Molar tooth sign on MRI (HP:0002419) | 2.47149647 |
| 68 | Abnormality of midbrain morphology (HP:0002418) | 2.47149647 |
| 69 | Increased IgM level (HP:0003496) | 2.46686202 |
| 70 | Cerebral hypomyelination (HP:0006808) | 2.46478759 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.44223507 |
| 72 | Abolished electroretinogram (ERG) (HP:0000550) | 2.43694926 |
| 73 | Hemoptysis (HP:0002105) | 2.43258324 |
| 74 | Eosinophilia (HP:0001880) | 2.43002307 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.41554333 |
| 76 | Muscle fiber atrophy (HP:0100295) | 2.40988526 |
| 77 | Keratoconjunctivitis sicca (HP:0001097) | 2.40876672 |
| 78 | Chronic diarrhea (HP:0002028) | 2.40801302 |
| 79 | Hypothermia (HP:0002045) | 2.40102324 |
| 80 | Vaginal atresia (HP:0000148) | 2.40081193 |
| 81 | Abnormality of the labia minora (HP:0012880) | 2.37017703 |
| 82 | Epistaxis (HP:0000421) | 2.36002944 |
| 83 | Chromsome breakage (HP:0040012) | 2.34820057 |
| 84 | Breast hypoplasia (HP:0003187) | 2.34671568 |
| 85 | Febrile seizures (HP:0002373) | 2.34061761 |
| 86 | Granulocytopenia (HP:0001913) | 2.32955017 |
| 87 | Hematochezia (HP:0002573) | 2.29968862 |
| 88 | Hypoproteinemia (HP:0003075) | 2.28424020 |
| 89 | Fetal akinesia sequence (HP:0001989) | 2.28138631 |
| 90 | Capillary hemangiomas (HP:0005306) | 2.28063715 |
| 91 | Recurrent bronchitis (HP:0002837) | 2.21953575 |
| 92 | Chest pain (HP:0100749) | 2.17366527 |
| 93 | Absent septum pellucidum (HP:0001331) | 2.17193271 |
| 94 | Pendular nystagmus (HP:0012043) | 2.16491431 |
| 95 | CNS hypomyelination (HP:0003429) | 2.16451588 |
| 96 | Recurrent viral infections (HP:0004429) | 2.16001697 |
| 97 | Spondylolisthesis (HP:0003302) | 2.15346443 |
| 98 | Toxemia of pregnancy (HP:0100603) | 2.14251220 |
| 99 | Combined immunodeficiency (HP:0005387) | 2.14247978 |
| 100 | Poikilocytosis (HP:0004447) | 2.13861370 |
| 101 | Severe visual impairment (HP:0001141) | 2.13178000 |
| 102 | Anorexia (HP:0002039) | 2.13173741 |
| 103 | Pustule (HP:0200039) | 2.12406644 |
| 104 | Urticaria (HP:0001025) | 2.11368248 |
| 105 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.11161104 |
| 106 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.11161104 |
| 107 | Recurrent abscess formation (HP:0002722) | 2.11032355 |
| 108 | Recurrent bacterial skin infections (HP:0005406) | 2.09991524 |
| 109 | Arterial tortuosity (HP:0005116) | 2.06950763 |
| 110 | Abnormality of the femoral head (HP:0003368) | 2.04988745 |
| 111 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04659006 |
| 112 | Retrobulbar optic neuritis (HP:0100654) | 2.03573150 |
| 113 | Optic neuritis (HP:0100653) | 2.03573150 |
| 114 | Amniotic constriction ring (HP:0009775) | 2.03502447 |
| 115 | Abnormality of placental membranes (HP:0011409) | 2.03502447 |
| 116 | Pulmonary fibrosis (HP:0002206) | 2.03432081 |
| 117 | Episodic fever (HP:0001954) | 2.03048247 |
| 118 | Abnormality of the pleura (HP:0002103) | 2.02713128 |
| 119 | Gingival bleeding (HP:0000225) | 2.02258847 |
| 120 | Decreased central vision (HP:0007663) | 2.02013669 |
| 121 | Facial hemangioma (HP:0000329) | 2.01286195 |
| 122 | Decreased circulating renin level (HP:0003351) | 2.01217399 |
| 123 | Abnormality of the septum pellucidum (HP:0007375) | 2.00503252 |
| 124 | B lymphocytopenia (HP:0010976) | 2.00270023 |
| 125 | Myokymia (HP:0002411) | 2.00073533 |
| 126 | Autoimmune thrombocytopenia (HP:0001973) | 1.99885522 |
| 127 | Peripheral hypomyelination (HP:0007182) | 1.99574716 |
| 128 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.98549613 |
| 129 | Infertility (HP:0000789) | 1.98015064 |
| 130 | Attenuation of retinal blood vessels (HP:0007843) | 1.97529397 |
| 131 | Lymphopenia (HP:0001888) | 1.95680924 |
| 132 | Aplastic anemia (HP:0001915) | 1.95616161 |
| 133 | Abnormality of iron homeostasis (HP:0011031) | 1.94438900 |
| 134 | Acute hepatic failure (HP:0006554) | 1.94337042 |
| 135 | Acute myeloid leukemia (HP:0004808) | 1.92844904 |
| 136 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.92428140 |
| 137 | Breast aplasia (HP:0100783) | 1.92190780 |
| 138 | Abnormality of alanine metabolism (HP:0010916) | 1.91420377 |
| 139 | Hyperalaninemia (HP:0003348) | 1.91420377 |
| 140 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91420377 |
| 141 | Neurofibrillary tangles (HP:0002185) | 1.90570376 |
| 142 | Gangrene (HP:0100758) | 1.90569625 |
| 143 | Tetany (HP:0001281) | 1.90522062 |
| 144 | Hypergonadotropic hypogonadism (HP:0000815) | 1.90189067 |
| 145 | Stomach cancer (HP:0012126) | 1.90125787 |
| 146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89752334 |
| 147 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.88786516 |
| 148 | Broad foot (HP:0001769) | 1.88601661 |
| 149 | Progressive inability to walk (HP:0002505) | 1.87888553 |
| 150 | Chronic sinusitis (HP:0011109) | 1.86846635 |
| 151 | Chronic otitis media (HP:0000389) | 1.86203782 |
| 152 | IgM deficiency (HP:0002850) | 1.85123398 |
| 153 | Thyroiditis (HP:0100646) | 1.84848228 |
| 154 | Weak cry (HP:0001612) | 1.84718937 |
| 155 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.84592287 |
| 156 | Recurrent sinusitis (HP:0011108) | 1.84580218 |
| 157 | Abnormality of the prostate (HP:0008775) | 1.84288740 |
| 158 | Progressive neurologic deterioration (HP:0002344) | 1.83956953 |
| 159 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.83470416 |
| 160 | Increased serum pyruvate (HP:0003542) | 1.83037312 |
| 161 | Abnormality of glycolysis (HP:0004366) | 1.83037312 |
| 162 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82656700 |
| 163 | Renal Fanconi syndrome (HP:0001994) | 1.82370297 |
| 164 | Renal cortical cysts (HP:0000803) | 1.82352317 |
| 165 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81744211 |
| 166 | Abnormal gallbladder physiology (HP:0012438) | 1.80385589 |
| 167 | Cholecystitis (HP:0001082) | 1.80385589 |
| 168 | Neutropenia (HP:0001875) | 1.78811905 |
| 169 | Thyroid carcinoma (HP:0002890) | 1.78004592 |
| 170 | Pulmonary embolism (HP:0002204) | 1.77799523 |
| 171 | Skin rash (HP:0000988) | 1.77648048 |
| 172 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77354731 |
| 173 | Patellar aplasia (HP:0006443) | 1.76400666 |
| 174 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.76235032 |
| 175 | Inflammation of the large intestine (HP:0002037) | 1.75651606 |
| 176 | Purpura (HP:0000979) | 1.74946575 |
| 177 | Abnormality of the fingertips (HP:0001211) | 1.74218356 |
| 178 | Abnormal albumin level (HP:0012116) | 1.72525701 |
| 179 | Hypoalbuminemia (HP:0003073) | 1.72525701 |
| 180 | Abnormality of lateral ventricle (HP:0030047) | 1.72343039 |
| 181 | Abnormal auditory evoked potentials (HP:0006958) | 1.70168568 |
| 182 | Central scotoma (HP:0000603) | 1.68647800 |
| 183 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.67457824 |
| 184 | Secondary amenorrhea (HP:0000869) | 1.67426933 |
| 185 | Anterior segment dysgenesis (HP:0007700) | 1.66775201 |
| 186 | Exertional dyspnea (HP:0002875) | 1.66738617 |
| 187 | Sensory axonal neuropathy (HP:0003390) | 1.66414717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K6 | 3.90749238 |
| 2 | MUSK | 3.59182972 |
| 3 | ARAF | 3.21077311 |
| 4 | KSR2 | 2.85662223 |
| 5 | MAP3K12 | 2.76692957 |
| 6 | GRK6 | 2.71275645 |
| 7 | MAP3K13 | 2.69510927 |
| 8 | FRK | 2.66167989 |
| 9 | STK38L | 2.65496517 |
| 10 | BRAF | 2.60326743 |
| 11 | RIPK4 | 2.57251483 |
| 12 | ERBB4 | 2.55998431 |
| 13 | MAP3K9 | 2.51828935 |
| 14 | PLK4 | 2.37920626 |
| 15 | LATS2 | 2.30362402 |
| 16 | RAF1 | 2.24807690 |
| 17 | IRAK4 | 2.23371690 |
| 18 | FES | 2.18616997 |
| 19 | MAPKAPK5 | 2.13348432 |
| 20 | BMPR2 | 2.13279598 |
| 21 | MOS | 2.12507581 |
| 22 | TAOK3 | 2.07277980 |
| 23 | MAP2K7 | 2.05852026 |
| 24 | LATS1 | 2.05113722 |
| 25 | SYK | 1.97050377 |
| 26 | CDK8 | 1.90738996 |
| 27 | DYRK2 | 1.81179462 |
| 28 | BLK | 1.79557674 |
| 29 | MAP3K4 | 1.76905231 |
| 30 | BTK | 1.75075805 |
| 31 | ITK | 1.68253919 |
| 32 | IKBKB | 1.64427696 |
| 33 | BCKDK | 1.61419901 |
| 34 | MAPK13 | 1.60907106 |
| 35 | MST4 | 1.59703568 |
| 36 | GRK1 | 1.56392968 |
| 37 | TNK2 | 1.54513854 |
| 38 | MAP2K3 | 1.52035692 |
| 39 | CSK | 1.48680937 |
| 40 | TLK1 | 1.45757419 |
| 41 | TYK2 | 1.44566446 |
| 42 | TBK1 | 1.44510652 |
| 43 | TAOK1 | 1.43961720 |
| 44 | OXSR1 | 1.43404632 |
| 45 | BMPR1B | 1.43113029 |
| 46 | PAK6 | 1.38538475 |
| 47 | LYN | 1.37133190 |
| 48 | ZAP70 | 1.36900692 |
| 49 | HCK | 1.35142785 |
| 50 | CDK3 | 1.33879111 |
| 51 | MAP2K6 | 1.32344459 |
| 52 | ZAK | 1.32017534 |
| 53 | TESK2 | 1.31557791 |
| 54 | LCK | 1.28021846 |
| 55 | MAPKAPK3 | 1.22894420 |
| 56 | MELK | 1.21910287 |
| 57 | KSR1 | 1.20598870 |
| 58 | KDR | 1.19929667 |
| 59 | TNIK | 1.19354027 |
| 60 | NLK | 1.17615051 |
| 61 | PTK2B | 1.15545927 |
| 62 | TTK | 1.14867112 |
| 63 | CSF1R | 1.14151782 |
| 64 | MAP2K4 | 1.13706816 |
| 65 | PRKCQ | 1.11656560 |
| 66 | CDK9 | 1.09713544 |
| 67 | STK39 | 1.06367376 |
| 68 | DAPK2 | 1.06187785 |
| 69 | CDK19 | 1.02949298 |
| 70 | MAP3K14 | 1.02537171 |
| 71 | PIK3CG | 1.02289416 |
| 72 | MAP3K11 | 1.01633235 |
| 73 | ACVR1B | 1.00933073 |
| 74 | JAK1 | 1.00732843 |
| 75 | CSNK1G3 | 1.00724207 |
| 76 | MAP4K2 | 1.00647335 |
| 77 | CSNK1G1 | 0.99833018 |
| 78 | TXK | 0.99579250 |
| 79 | PIM1 | 0.99554764 |
| 80 | MARK3 | 0.98042496 |
| 81 | MAP2K2 | 0.94471280 |
| 82 | JAK2 | 0.93068659 |
| 83 | GRK7 | 0.92457476 |
| 84 | SGK494 | 0.87661877 |
| 85 | SGK223 | 0.87661877 |
| 86 | ADRBK1 | 0.87001274 |
| 87 | EEF2K | 0.86467807 |
| 88 | ERN1 | 0.85494377 |
| 89 | CSNK1G2 | 0.83678278 |
| 90 | MATK | 0.83404778 |
| 91 | STK3 | 0.81488558 |
| 92 | SIK3 | 0.77553749 |
| 93 | CHEK2 | 0.77540358 |
| 94 | ABL2 | 0.76479065 |
| 95 | CASK | 0.75948491 |
| 96 | EPHA3 | 0.75065665 |
| 97 | VRK1 | 0.74888771 |
| 98 | CAMKK2 | 0.73713983 |
| 99 | CAMK2A | 0.73444328 |
| 100 | KIT | 0.72540716 |
| 101 | CDC7 | 0.71466600 |
| 102 | HIPK2 | 0.71011860 |
| 103 | STK24 | 0.70877280 |
| 104 | PINK1 | 0.69854932 |
| 105 | MAP3K3 | 0.68221068 |
| 106 | FGR | 0.63946845 |
| 107 | STK16 | 0.63530790 |
| 108 | MARK2 | 0.63390092 |
| 109 | BCR | 0.62573473 |
| 110 | EIF2AK3 | 0.59329381 |
| 111 | PRKD2 | 0.58812779 |
| 112 | RET | 0.58189321 |
| 113 | GRK5 | 0.57522755 |
| 114 | CSNK1A1L | 0.57131847 |
| 115 | SGK2 | 0.56249925 |
| 116 | TRPM7 | 0.55989755 |
| 117 | PBK | 0.55953052 |
| 118 | JAK3 | 0.55009716 |
| 119 | IRAK1 | 0.53682913 |
| 120 | TEC | 0.52898950 |
| 121 | EPHB1 | 0.51609176 |
| 122 | STK38 | 0.48734582 |
| 123 | STK10 | 0.47213943 |
| 124 | ADRBK2 | 0.46325020 |
| 125 | TGFBR2 | 0.45572201 |
| 126 | ABL1 | 0.45068306 |
| 127 | INSRR | 0.44828573 |
| 128 | NEK6 | 0.43696780 |
| 129 | STK11 | 0.42799333 |
| 130 | PLK1 | 0.42414428 |
| 131 | EIF2AK1 | 0.41994408 |
| 132 | DAPK1 | 0.41604610 |
| 133 | MAP3K1 | 0.40119707 |
| 134 | MYLK | 0.38665356 |
| 135 | CDK18 | 0.38555217 |
| 136 | PDK1 | 0.38361407 |
| 137 | MAP4K1 | 0.38106180 |
| 138 | PAK3 | 0.37975864 |
| 139 | FYN | 0.37935895 |
| 140 | DYRK3 | 0.36527790 |
| 141 | PRPF4B | 0.36505173 |
| 142 | DYRK1A | 0.36397879 |
| 143 | PRKCD | 0.36327640 |
| 144 | IKBKE | 0.35640674 |
| 145 | CLK1 | 0.35598059 |
| 146 | NTRK2 | 0.35596665 |
| 147 | CDK15 | 0.35541663 |
| 148 | MAPK11 | 0.34769070 |
| 149 | CAMK2G | 0.33844390 |
| 150 | PRKAA1 | 0.33552066 |
| 151 | PLK3 | 0.32226890 |
| 152 | IGF1R | 0.32156861 |
| 153 | PRKD3 | 0.31824509 |
| 154 | BUB1 | 0.31393390 |
| 155 | MAP3K5 | 0.30312273 |
| 156 | MAPKAPK2 | 0.29219503 |
| 157 | RPS6KA5 | 0.28945896 |
| 158 | PLK2 | 0.27879818 |
| 159 | PRKAA2 | 0.27857800 |
| 160 | CDK11A | 0.27171178 |
| 161 | NUAK1 | 0.26578472 |
| 162 | MAP2K1 | 0.26358714 |
| 163 | PRKCE | 0.25675727 |
| 164 | AURKA | 0.25494637 |
| 165 | CAMK2D | 0.25209464 |
| 166 | CAMK2B | 0.25113246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.05672092 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.96001060 |
| 3 | Basal transcription factors_Homo sapiens_hsa03022 | 2.89059657 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.69420578 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.59153750 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.54628205 |
| 7 | Circadian rhythm_Homo sapiens_hsa04710 | 2.47250167 |
| 8 | RNA degradation_Homo sapiens_hsa03018 | 2.40266997 |
| 9 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.16652856 |
| 10 | Cell cycle_Homo sapiens_hsa04110 | 2.14506339 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.14346784 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.11991044 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.08393749 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.93916847 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.88966787 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.84911233 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.84869383 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.81041891 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.79677816 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.60298231 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.60247883 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57718504 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55601064 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55136260 |
| 25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.50736091 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47879415 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.44248417 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.43667838 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41312045 |
| 30 | Nicotine addiction_Homo sapiens_hsa05033 | 1.38111587 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36412609 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.34151538 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33481705 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32346771 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.30771531 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30767316 |
| 37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.29215819 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.28848965 |
| 39 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.28227523 |
| 40 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.21016887 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20929391 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.20750784 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.20742580 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.20706764 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18826187 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 1.17093373 |
| 47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.16416378 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.16234534 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11795322 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11168755 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10485741 |
| 52 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.10137501 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05713990 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04319446 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02762164 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.00170204 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 0.99800681 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97360252 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.97224531 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95052341 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94673826 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94031757 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93640895 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90922745 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90651434 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89068392 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88978611 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.88405019 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87632714 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87336634 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86756885 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86738917 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.86560265 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86279979 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.85969982 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.85019118 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84686420 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.83100766 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82944583 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82385638 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82350014 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81647097 |
| 83 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.80312767 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79590753 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.77833072 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77326916 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75932931 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.75031040 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.74873420 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.74609264 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.73819319 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73444102 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72902003 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72819630 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69655300 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68622054 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68483999 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.68439894 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68259916 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67859260 |
| 101 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67199731 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66649276 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64626268 |
| 104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62932984 |
| 105 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62898309 |
| 106 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62135650 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.61945965 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61571978 |
| 109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61117137 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60855871 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60497255 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60399639 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60208605 |
| 114 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59791214 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59053274 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58163546 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58127737 |
| 118 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56818477 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56596312 |
| 120 | Base excision repair_Homo sapiens_hsa03410 | 0.55850292 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55264827 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53160153 |
| 123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51342691 |
| 124 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50797591 |
| 125 | Allograft rejection_Homo sapiens_hsa05330 | 0.50539225 |
| 126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49504766 |
| 127 | Lysosome_Homo sapiens_hsa04142 | 0.49364082 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.49314394 |
| 129 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49237580 |
| 130 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49166278 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48928398 |
| 132 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48195334 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.47748907 |
| 134 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47578584 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47345113 |
| 136 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46704204 |
| 137 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46599162 |
| 138 | Leishmaniasis_Homo sapiens_hsa05140 | 0.46462325 |
| 139 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45626425 |
| 140 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43162899 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.43090223 |
| 142 | Phagosome_Homo sapiens_hsa04145 | 0.42253201 |
| 143 | Salmonella infection_Homo sapiens_hsa05132 | 0.41410841 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41098720 |
| 145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38709085 |
| 146 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38461799 |
| 147 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35655780 |
| 148 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35589231 |
| 149 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.34675038 |
| 150 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33895751 |
| 151 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33725803 |
| 152 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30510762 |
| 153 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27817128 |
| 154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.27773763 |
| 155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22482507 |
| 156 | Taste transduction_Homo sapiens_hsa04742 | 0.20618281 |
| 157 | Retinol metabolism_Homo sapiens_hsa00830 | 0.19112069 |

